Authors:
LINDER J
MELANDER A
LARSSON M
BERGENGREN Y
Citation: J. Linder et al., FATIGUE DESIGN OF SPOT-WELDED AUSTENITIC AND DUPLEX STAINLESS SHEET STEELS, Fatigue & fracture of engineering materials & structures, 21(6), 1998, pp. 673-686
Authors:
HENRICSON K
STENBERG P
RAMETSTEINER G
RANSTAM J
HANSON BS
MELANDER A
Citation: K. Henricson et al., SOCIOECONOMIC-FACTORS, MORBIDITY AND DRUG UTILIZATION - AN ECOLOGICALSTUDY, Pharmacoepidemiology and drug safety, 7(4), 1998, pp. 261-267
Authors:
LINDBERG G
RANSTAM J
MELANDER A
BINGEFORS K
RASTAM L
Citation: G. Lindberg et al., USE OF CALCIUM-CHANNEL BLOCKERS AND RISK OF SUICIDE - REPLY, BMJ. British medical journal, 317(7165), 1998, pp. 1077-1077
Authors:
LINDBERG G
BINGEFORS K
RANSTAM J
RASTAM L
MELANDER A
Citation: G. Lindberg et al., USE OF CALCIUM-CHANNEL BLOCKERS AND RISK OF SUICIDE - ECOLOGICAL FINDINGS CONFIRMED IN POPULATION-BASED COHORT STUDY, BMJ. British medical journal, 316(7133), 1998, pp. 741-745
Authors:
BOGHANSEN E
LINDBLAD U
BENGTSSON K
RANSTAM J
MELANDER A
RASTAM L
Citation: E. Boghansen et al., RISK FACTOR CLUSTERING IN PATIENTS WITH HYPERTENSION AND NON-INSULIN-DEPENDENT DIABETES-MELLITUS - THE SKARABORG-HYPERTENSION-PROJECT, Journal of internal medicine, 243(3), 1998, pp. 223-232
Citation: Hbt. Christesen et A. Melander, PROLONGED ELIMINATION OF TOLBUTAMIDE IN A PREMATURE NEWBORN WITH HYPERINSALINAEMIC HYPOGLYCEMIA, European journal of endocrinology, 138(6), 1998, pp. 698-701
Citation: J. Linder et A. Melander, FATIGUE-STRENGTH OF SPOT WELDED STAINLESS SHEET STEELS EXPOSED TO 3-PERCENT NACL SOLUTION, International journal of fatigue, 20(5), 1998, pp. 383-388
Authors:
HENRICSON K
MELANDER E
MOLSTAD S
RANSTAM J
HANSON BS
RAMETSTEINER G
STENBERG P
MELANDER A
Citation: K. Henricson et al., INTRAURBAN VARIATION OF ANTIBIOTIC UTILIZATION IN CHILDREN - INFLUENCE OF SOCIOECONOMIC-FACTORS, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 653-657
Citation: A. Jonsson et al., PHARMACOKINETICS OF GLIBENCLAMIDE AND ITS METABOLITES IN DIABETIC-PATIENTS WITH IMPAIRED RENAL-FUNCTION, European Journal of Clinical Pharmacology, 53(6), 1998, pp. 429-435
Authors:
MELANDER A
LINDBERG G
OLSSON J
RANSTAM J
RASTAM L
Citation: A. Melander et al., INCREASED MORTALITY IN NIDDM PATIENTS ON ANTIHYPERTENSIVE TREATMENT WITH CALCIUM-CHANNEL BLOCKERS, Diabetologia, 41, 1998, pp. 1357-1357
Authors:
RANSTAM J
MERLO J
BLENNOW G
HANSON BS
OSTERGREN PO
MELANDER A
Citation: J. Ranstam et al., IMPAIRED COGNITIVE FUNCTION IN ELDERLY MEN EXPOSED TO BENZODIAZEPINESOR OTHER ANXIOLYTICS, European journal of public health, 7(2), 1997, pp. 149-152
Authors:
RYDBERG T
JONSSON A
KARLSSON MO
MELANDER A
Citation: T. Rydberg et al., CONCENTRATION-EFFECT RELATIONS OF GLIBENCLAMIDE AND ITS ACTIVE METABOLITES IN MAN - MODELING OF PHARMACOKINETICS AND PHARMACODYNAMICS, British journal of clinical pharmacology, 43(4), 1997, pp. 373-381
Citation: A. Melander, A FINITE-ELEMENT STUDY OF SHORT CRACKS WITH DIFFERENT INCLUSION TYPESUNDER ROLLING-CONTACT FATIGUE LOAD, International journal of fatigue, 19(1), 1997, pp. 13-24
Citation: A. Jonsson et al., PHARMACOKINETICS OF GLIBENCLAMIDE AND ITS METABOLITES IN DIABETIC SUBJECTS WITH NORMAL AND WITH IMPAIRED RENAL-FUNCTION, Diabetologia, 40, 1997, pp. 1252-1252
Authors:
MERLO J
RANSTAM J
LIEDHOLM H
HEDBLAD B
LINDBERG G
LINDBLAD U
ISACSSON SO
MELANDER A
RASTAM L
Citation: J. Merlo et al., INCIDENCE OF MYOCARDIAL-INFARCTION IN ELDERLY MEN BEING TREATED WITH ANTIHYPERTENSIVE DRUGS - POPULATION-BASED COHORT STUDY, BMJ. British medical journal, 313(7055), 1996, pp. 457-461
Authors:
MANSSON NO
ERIKSSON KF
ISRAELSSON B
RANSTAM J
MELANDER A
RASTAM L
Citation: No. Mansson et al., BODY-MASS INDEX AND DISABILITY PENSION IN MIDDLE-AGED MEN - NONLINEARRELATIONS, International journal of epidemiology, 25(1), 1996, pp. 80-85
Citation: A. Melander et A. Gustavsson, AN FEM STUDY OF DRIVING FORCES OF SHORT CRACKS AT INCLUSIONS IN HARD STEELS, International journal of fatigue, 18(6), 1996, pp. 389-399
Citation: J. Merlo et al., COMPARISON OF DOSE STANDARD UNITS FOR DRUG UTILIZATION STUDIES, European Journal of Clinical Pharmacology, 50(1-2), 1996, pp. 27-30